• Users Online: 209
  • Print this page
  • Email this page
ORIGINAL ARTICLE
Year : 2022  |  Volume : 23  |  Issue : 1  |  Page : 81-85

Effectiveness of salbutamol administered through a metered-dose inhaler with nebuliser amongst children for acute asthma treatment


1 Assistant Professor, Department of Pediatric Nursing, TN MGR Medical University, Tamil Nadu, India
2 Professor, Department of Child Health, TN MGR Medical University, Tamil Nadu, India
3 Charge Nurse, Department of Pediatric Nursing, TN MGR Medical University, Tamil Nadu, India
4 Respiratory Therapist, Department of Child Health, TN MGR Medical University, Tamil Nadu, India
5 Professor, Department of Pediatric Nursing, College of Nursing, Christian Medical College, Vellore, TN MGR Medical University, Tamil Nadu, India

Correspondence Address:
Ms. Deena Edwin
College of Nursing, Christian Medical College, Vellore, Tamil Nadu
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijcn.ijcn_98_21

Rights and Permissions

Administration of salbutamol by metered-dose inhaler (MDI) with spacer is as effective as nebuliser in terms of clinical response and patient outcome. In addition, fewer side effects and lesser hospital admission rates are recorded with this method. Changing the practice of using nebuliser to MDI with spacer as the preferred mode of treatment for mild-to-moderate asthma has been studied. In this study, 68 children between the age groups of 5 and 18 years with mild-to-moderate severity of asthma admitted in the paediatric emergency service and the child health outpatient department were studied to compare the effect of salbutamol delivered via MDI with salbutamol through nebuliser for acute asthma treatment. In this study, 70 children with asthma were randomly allocated to the MDI and nebuliser groups. The standardised Modified Pulmonary Index Score was assessed by the clinical assessor before and 10 min after the intervention. The findings revealed that the clinical outcome was highly significant in both the groups. However, the feasibility of using MDI with spacer in comparison to nebuliser was found to be highly significant in relation to the effectiveness, utilisation of hospital resources (treatment preparation, delivery time and cost) and acceptability to patients. Results of the study carried out in the paediatric population indicate that MDI with spacer is as effective as nebuliser in the treatment of children with mild and moderate acute asthma exacerbations in the hospital setting. However, MDI with spacer has more additional benefits such as fewer side effects, less time consumed to administer the treatment, cost-effective, portable and easier to use than nebulisers.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1069    
    Printed38    
    Emailed0    
    PDF Downloaded87    
    Comments [Add]    

Recommend this journal